Lipid Panel Explained — What Every Marker on Your Cholesterol Test Means

A lipid panel (also called a lipid profile or fasting lipids) measures the different types of fat and cholesterol circulating in your blood. It is one of the most ordered blood tests in the world — yet most people only hear about LDL and HDL. Here is a complete guide to every marker on the panel.

Clinical note: Lipid targets are not one-size-fits-all. Treatment decisions depend on your overall 10-year cardiovascular risk score (such as ASCVD or QRISK), not just individual numbers. A clinician may target LDL below 70 mg/dL for a high-risk patient while accepting 130 mg/dL for a low-risk young adult.

What is a lipid panel and when is it ordered?

A lipid panel measures fats (lipids) in the blood to assess cardiovascular risk. It is ordered as a routine screen in adults (usually from age 20–35 onward), when monitoring response to lipid-lowering medication, or when evaluating risk factors like diabetes, hypertension, obesity, or family history of early heart disease.

Most panels require fasting for 9–12 hours, because triglycerides rise significantly after eating. Non-fasting lipid panels are increasingly acceptable for initial screening since they are more convenient, though triglyceride results will be higher.

Every marker on the lipid panel — explained

Total Cholesterol (TC)

The sum of all cholesterol in the blood: LDL + HDL + VLDL. A screening figure — high or low alone tells you little without the breakdown.

Desirable< 200 mg/dL (< 5.2 mmol/L)

Concern threshold≥ 240 mg/dL borderline-high to high

LDL Cholesterol (LDL-C)

Low-density lipoprotein — carries cholesterol from the liver to tissues. Elevated LDL is associated with arterial plaque build-up (atherosclerosis). The primary treatment target in most guidelines.

Desirable< 100 mg/dL optimal; < 130 mg/dL near-optimal

Concern threshold≥ 160 mg/dL high; higher risk individuals target < 70 mg/dL

HDL Cholesterol (HDL-C)

High-density lipoprotein — transports cholesterol back to the liver for removal. Higher HDL is generally protective. Low HDL is an independent cardiovascular risk factor.

Desirable≥ 60 mg/dL (1.55 mmol/L) — protective

Concern threshold< 40 mg/dL in men; < 50 mg/dL in women — low, increases risk

Triglycerides (TG)

The main fat molecule stored in the body and transported in blood after meals. Elevated TG often accompanies low HDL and raised VLDL as part of atherogenic dyslipidaemia.

Desirable< 150 mg/dL (< 1.7 mmol/L)

Concern threshold≥ 200 mg/dL high; ≥ 500 mg/dL — risk of pancreatitis

VLDL Cholesterol (VLDL-C)

Very-low-density lipoprotein — rich in triglycerides. Usually estimated (TG ÷ 5 in mg/dL). VLDL delivers TG to peripheral tissues; excess VLDL contributes to cardiovascular risk.

Desirable2–30 mg/dL (0.1–0.77 mmol/L)

Concern thresholdAbove 30 mg/dL — elevated

Non-HDL Cholesterol (Non-HDL-C)

Total cholesterol minus HDL. Captures all atherogenic lipoproteins (LDL + VLDL + IDL + Lp(a)). Can be calculated without fasting and is increasingly favoured as a risk marker.

Desirable< 130 mg/dL (< 3.4 mmol/L) — optimal

Concern threshold≥ 160 mg/dL — above target for most adults

Cholesterol ratios — what they add

Some reports include ratios derived from the panel. These are not diagnostic by themselves but give additional risk context:

Total cholesterol / HDL ratio — below 4.0 is generally considered favourable. A ratio above 5 indicates increasing risk.
LDL / HDL ratio — below 3.0 is often cited as a target; below 2.0 is considered optimal.
Triglycerides / HDL ratio — a ratio above 3.5 (mg/dL units) is associated with insulin resistance and metabolic syndrome. This ratio is less useful if you use mmol/L — ensure you use consistent units.

None of these ratios replace individual marker assessment. They are tools for discussion with your clinician, not standalone risk calculators.

Atherogenic dyslipidaemia — a common pattern to recognise

A pattern of high triglycerides + low HDL + small, dense LDL particles is called atherogenic dyslipidaemia. It is strongly associated with type 2 diabetes, insulin resistance, metabolic syndrome, and abdominal obesity. Total cholesterol may appear normal or only modestly elevated — which is why looking at the full panel matters.

LDL-C alone may underestimate risk in this pattern. Non-HDL-C or ApoB (apolipoprotein B) testing better captures the burden of atherogenic particles in these individuals.

ApoB and Lp(a) — beyond the standard panel

ApoB (apolipoprotein B)

Each atherogenic lipoprotein particle (LDL, VLDL, IDL, Lp(a)) carries one ApoB molecule. ApoB is therefore a direct count of atherogenic particles — more precise than LDL-C alone, particularly in people with high TG or metabolic syndrome. It is not on every standard panel but is increasingly recommended in high-risk individuals.

Lp(a) — lipoprotein(a)

Lp(a) is a genetically determined lipoprotein that carries additional cardiovascular risk independent of LDL. It is not routinely tested but recommended at least once in adults with family history of early cardiovascular disease or familial hypercholesterolaemia. High Lp(a) is not lowered by statins.

What affects lipid levels?

Diet — saturated fat and trans fat raise LDL; omega-3 fatty acids lower TG; refined carbohydrates raise TG
Physical activity — regular exercise raises HDL and lowers TG
Weight — excess adiposity lowers HDL and raises TG and LDL
Smoking — lowers HDL
Alcohol — moderate alcohol raises HDL but high intake raises TG significantly
Thyroid function — hypothyroidism markedly raises LDL
Medications — statins, fibrates, omega-3, ezetimibe, PCSK9 inhibitors, and others directly alter lipid levels
Genetics — familial hypercholesterolaemia causes very high LDL (typically LDL > 190 mg/dL) regardless of diet

Statin therapy and lipid monitoring

If you are on a statin, lipid panels are repeated 4–12 weeks after starting or changing dose, then annually once stable. The goal is not a target number in isolation but a percentage reduction in LDL-C (typically 30–50% for moderate-intensity statins,>50% for high-intensity statins) plus achievement of individual risk-based targets.

Get your lipid panel results explained

Upload your blood test report to our AI analyzer — it reads every marker against your lab's own reference range and explains each value in plain language.

Analyze my blood test →

Trusted reference sources

For educational purposes only. Not medical advice. Lipid management decisions depend on your individual cardiovascular risk profile. Discuss your results and any treatment options with a qualified clinician.